Clinical Trial

Performance and Impact of the Sepsis ImmunoScore

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.
Trial Details
NCT Number NCT07543497
Lead Sponsor Prenosis, Inc.
Conditions Sepsis
Enrollment 5,000 participants
Start Date 2026-04
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-22